Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc

Bullboard Posts

Comment by canadapieton Feb 28, 2020 1:59pm

75 Views

Post# 30748179

RE:RE:RE:Weekly Sales Update

I believe in people being honest, so i believe mr. T. when he says how
things are going!! But for sure i don't know if the sales are from the
transfert of the old version.........
So,again, the benefit of the doubt for now. We will see after second Q....

qwerty22 - (2/28/2020 12:22:55 PM)
RE:RE:Weekly Sales Update

"SV sales"? Specifically "SV sales"? Not total Egrifta sales? 40% up compared to what? That could mean literally anything. Did you ask him to clarify what he meant?

It's like an evil Haiku. Very few words are said but each word is chosen carefully to ensure a maximum lack of understanding.

Bullboard Posts

Anaergia expands relationship with PepsiCo